Clinical Trials Directory

Trials / Completed

CompletedNCT03158961

The Feasibility and Safety of the TOETVA for Benign Thyroid Nodules

A Prospective Evaluation of the Feasibility and Safety of the Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA) as a Treatment for Benign Thyroid Nodules

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
The University of Hong Kong · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Thyroid surgery has been developed as a new technique for zero scar in surgery by applying transoral endoscopic thyroidectomy with sublingual approach. The new technique is locating the surgery which pierced through floor of mouth, cause severe tissue damage, high complication, and conversion rates to open surgery and surgical difficulties due to limitation of movement. Nevertheless, each report is still including small number of patients. Recently, the transoral endoscopic thyroidectomy vestibular approach (TOETVA) has been proven feasible and safe in several overseas centers. Moreover, a successful TOETVA case was reported in local media in the late last year. Hence, this study is for evaluating the feasibility and safety of the TOETVA prospectively at a tertiary referral center in Hong Kong. The following are the procedure of the study: 1. Recruit patients from the clinic. 2. Patients will receive treatment within 3 months 3. Patients will have different assessments like Ultrasonography assessment, Fine needle biopsy, Direct laryngoscopy, and Cosmectic scoring in Pre-operation, post-operation 2 week, post 1 month, post 3 month, post 6 month and post 12 month. 4. Patients will be monitoring by the same team after the study.

Conditions

Interventions

TypeNameDescription
PROCEDURETransoral endoscopic thyroidectomy vestibular approachTOVETA is a new approach in surgery of thyroidectomy no longer open on the neck

Timeline

Start date
2017-07-01
Primary completion
2019-05-31
Completion
2019-07-31
First posted
2017-05-18
Last updated
2021-04-28

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT03158961. Inclusion in this directory is not an endorsement.